IN-30778

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameIN-30778
Drug Alias NameIN-30778IN30778
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTumor-associated antigen modulators
TargetsTumor-associated antigen
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInxmed (nanjing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInxmed (nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A